Find latest Myeloma videos · 100+ videos

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub
O

ASH 2024 Insights: Cilta-Cel CAR-T in High-Risk SMM - Results From CAR-PRISM Study

By 2024 ASH Annual Meeting Insights Hub FEATURING Omar Nadeem
By 2024 ASH Annual Meeting Insights Hub FEATURING Omar Nadeem
1 view
December 16, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

2024 ASH Annual Meeting Insights Hub: Myeloma Videos

06:10

New

ASH 2024 Insights: Ide-Cel in NDMM With Inadequate Response to 1L AS…

2024 ASH Annual Meeting Insights Hub

B. Paul

04:01

New

ASH 2024 Insights: Optimizing Therapy Duration for Transplant-Inelig…

2024 ASH Annual Meeting Insights Hub

C. Pawlyn

05:58

New

ASH 2024 Insights: Efficacy and Safety of Selinexor, Pomalidomide, a…

2024 ASH Annual Meeting Insights Hub

M. Baljevic

View All

Related Videos

15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

506 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

169 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.2K views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

465 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

625 views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

648 views
15:46

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

426 views
09:07

CARTITUDE-4 Update: OS With Cilta-Cel vs. SOC in Len-Refractory Mult…

Maria-Victoria Mateos

215 views
20:23

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

411 views
21:41

Multiple Myeloma: Hot Topics in 2024

Yale Cancer Center

S. Browning

193 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

294 views
24:23

Will CAR-Ts and Bispecifics Replace HSCT in Myeloma?

MyCancerHaven

R. Vij, S. Al Hadidi

624 views
36:10

Highlights in Plasma Cell Disorders From ASCO® and EHA

Insights from 2024 EHA Annual Meeting

S. Al Hadidi

474 views
12:49

The Relapsed and Refractory MM Patient: When Immune Approaches Are I…

Joseph Mikhael

95 views
16:42

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

H. Hashmi

1.6K views
17:22

Highlights of Recent Updates in Myeloma: Part 2 - R/R Treatment

2024 ASCO® Annual Meeting Insights Hub

A. Jakubowiak

260 views
22:45

CAR T-Cells in Multiple Myeloma in 2024

Dana-Farber Cancer Institute

A. Sperling

270 views
13:22

Managing Infectious Complications With Bispecific and CAR-T Therapy …

SOHO Brazil 2024

N. S. Raje

193 views
26:46

CAR-Ts Earlier in MyelomaTherapy?: What We Learned From the Recent F…

Samer Al Hadidi

605 views
05:35

Bispecifics & CAR-Ts in MM: How to Choose and How to Sequence

Saurabh Chhabra

383 views
AUTOPLAY